<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000321390"><TermName>TZT-1027</TermName><TermDefinition><DefinitionText>A substance being studied in the treatment of cancer. It is a type of tubulin inhibitor. Also called soblidotin.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>TZT-1027</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento del cáncer. Es un tipo de inhibidor de la tubulina. También se llama soblidotina.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2003-07-26</DateFirstPublished><DateLastModified>2008-11-21</DateLastModified></GlossaryTerm>
